Using machine learning to predict blood sugar control and weight loss in people taking GLP-1 receptor drugs

Machine learning models were developed to predict glycemic control and weight loss outcomes following GLP-1 receptor agonist initiation.

• Significant variability in glycemic and weight loss outcomes exists among individuals using GLP-1 receptor agonists.
• Real-world data were utilized to enhance the prediction of treatment response.
• Key features influencing individual responses to GLP-1 receptor agonists may be identified through these models.

Simplified